PRE
Prenetics Global Limited NASDAQ Listed Jul 16, 2021$22.97
+0.17%
vs $22.93
Mkt Cap $390.5M
52w Low $11.37
73.1% of range
52w High $27.24
50d MA $21.52
200d MA $19.05
P/E (TTM)
—
EV/EBITDA
—
P/B
1.9x
Debt/Equity
0.0x
ROE
1.1%
P/FCF
-14.7x
RSI (14)
36.70
ATR (14)
$1.48
Beta
0.27
50d MA
$21.52
200d MA
$19.05
Avg Volume
264.2K
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Unit 701-706, K11 Atelier King’s Road · Quarry Bay, K3 000000 · HK
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | BMO | -0.64 | -0.53 | +16.5% | 19.37 | +1.2% | +0.2% | -3.3% | -4.2% | +12.4% | +8.0% | — |
| Jun 10, 2026 | BMO | -0.49 | -1.36 | -177.6% | 20.93 | -3.5% | -8.0% | +7.5% | +4.5% | -4.1% | -1.2% | — |
| May 14, 2026 | TNS | -0.49 | -1.14 | -131.6% | 17.59 | -0.2% | -11.3% | -6.9% | +0.6% | +5.8% | +2.9% | — |
| Feb 18, 2026 | BMO | -0.41 | -1.75 | -326.8% | 20.06 | +2.2% | -3.8% | -11.7% | -8.4% | +1.9% | +6.5% | — |
| Nov 10, 2025 | BMO | -0.55 | -0.41 | +25.5% | 11.89 | +5.1% | +8.7% | +7.3% | -2.9% | -9.4% | -3.4% | — |
| Sep 12, 2025 | BMO | -0.71 | -0.82 | -15.5% | 10.07 | +1.3% | -2.9% | -3.0% | +13.0% | +1.1% | +10.7% | — |
| Jun 12, 2025 | BMO | -0.80 | -0.80 | +0.0% | 8.02 | -4.9% | -12.6% | +0.0% | +7.1% | +23.3% | -3.2% | — |
| Mar 5, 2025 | BMO | -0.72 | -0.94 | -30.6% | 4.79 | +4.0% | +0.0% | -0.8% | -4.8% | -2.7% | +2.0% | — |
| Nov 27, 2024 | BMO | -0.93 | -0.88 | +5.4% | 4.43 | +1.6% | +1.1% | -4.0% | +0.0% | +2.3% | +13.6% | — |
| Nov 25, 2024 | BMO | -0.86 | -0.84 | +2.3% | 4.42 | +7.2% | +2.0% | -0.2% | -1.6% | +1.1% | -4.0% | — |
| Oct 4, 2024 | BMO | -0.93 | -0.88 | +5.4% | 4.30 | +0.0% | +14.9% | -6.9% | -8.9% | -7.4% | +8.2% | — |
| Sep 27, 2024 | BMO | -0.93 | -0.15 | +83.9% | 4.12 | +6.6% | -2.9% | +6.5% | -2.8% | +3.9% | +14.9% | — |
| Jun 18, 2024 | BMO | -1.02 | -0.38 | +63.0% | 5.95 | -0.2% | +2.4% | -1.5% | +0.7% | +0.8% | +0.3% | — |
| Apr 2, 2024 | BMO | -0.75 | -1.57 | -109.3% | 4.22 | -2.1% | -11.8% | -2.2% | -3.6% | +3.4% | +4.1% | — |
| Mar 26, 2024 | BMO | -4.80 | 0.90 | +118.8% | 3.56 | -1.1% | +0.3% | +13.4% | +4.2% | -11.8% | -2.2% | — |
| Nov 20, 2023 | BMO | -1.20 | -0.08 | +93.3% | 4.70 | -0.9% | +0.0% | -1.9% | -0.9% | +6.3% | -8.0% | — |
| Sep 15, 2023 | BMO | -0.05 | -0.15 | -200.0% | 7.50 | -2.0% | +0.0% | -2.8% | +0.0% | -4.1% | +2.4% | — |
| Jun 5, 2023 | BMO | -0.06 | -0.60 | -900.0% | 14.25 | -2.9% | +0.2% | -5.3% | -1.8% | -0.7% | +0.2% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 17 | Craig Hallum | Initiates | Buy | $40 | $22.02 | $21.65 | -1.7% | +9.9% | +0.0% | +0.6% | -5.9% | -0.8% |
| Aug 27 | B. Riley Securities | Initiates | Buy | $37 | $25.78 | $25.55 | -0.9% | +1.8% | -1.9% | +1.9% | -1.7% | +0.9% |
| Jun 16 | The Benchmark Company | Initiates | Buy | $30 | $20.75 | $21.00 | +1.2% | -1.2% | -3.2% | +3.2% | -2.6% | -0.2% |
| Oct 29 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $12.23 | $12.24 | +0.1% | +13.0% | +2.4% | +4.7% | -8.4% | -5.6% |
| Jan 16 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $6.00 | $5.82 | -3.0% | -1.2% | -4.6% | +6.0% | -4.7% | -0.2% |
| Dec 4 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $4.30 | $4.40 | +2.3% | +2.3% | +13.6% | +3.2% | +0.6% | +0.4% |
| Apr 4 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $3.64 | $3.63 | -0.3% | -3.6% | +3.4% | +4.1% | +7.7% | -2.0% |
| Sep 25 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $7.16 | $6.95 | -2.9% | -3.6% | -2.2% | +6.2% | +0.4% | +1.1% |
| Sep 18 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $7.50 | $7.35 | -2.0% | +0.0% | -2.8% | +0.0% | -4.1% | +2.4% |
| Aug 21 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $8.55 | $8.55 | +0.0% | -2.9% | +5.8% | -7.7% | -16.8% | +2.4% |
| Jan 18 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $22.95 | $24.75 | +7.8% | +6.5% | -5.5% | +0.6% | +6.5% | -4.8% |
No insider trades available.
No recent filings available.
Institutional (13F) — Top 0
All ↗
No 13F holders found.
Mutual Funds / ETFs (N-PORT) — Top 14
All ↗
Valuation
Market Cap
$390.5M
Enterprise Value
$261.8M
P/E (TTM)
—
Forward P/E
—
PEG Ratio
-0.27x
P/B
1.85x
P/S
2.74x
P/FCF
-14.66x
EV/EBITDA
—
Shares Out
14.1M
Financials (TTM)
Revenue
$142.6M
Net Income
-$67.6M
EBITDA
-$62.5M
Free Cash Flow
-$22.0M
Op Cash Flow
-$21.8M
EPS Basic
$-4.15
EPS Diluted
$-4.16
EPS Forward
$-3.15
Gross Margin
62.6%
Op Margin
-35.2%
Net Margin
-47.4%
Balance Sheet
Total Assets
$203.5M
Total Liab.
$29.0M
Total Equity
$174.5M
Cash
$61.5M
LT Debt
$437K
Book Value/Sh
$12.42
Debt/Equity
0.01x
Current Ratio
3.01
Quick Ratio
2.76
Returns & Growth
ROE
1.1%
ROA
0.3%
ROIC
-21.1%
Rev Growth YoY
+201.7%
EPS Growth YoY
-14.0%
Price Returns
2W
-2.1%
1M
-10.9%
3M
+22.0%
6M
+7.7%
12M
+82.7%
Technicals
52W High
$27.24
52W Low
$11.37
50d MA
$21.52
200d MA
$19.05
RSI (14)
36.70
ATR (14)
$1.48
Beta
0.27
Avg Volume
264K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
Feb 17, 2016
Analyst Price Targets
Consensus
$36.00
High
$36.00
Low
$36.00
Median
$36.00
Data updated apr 26, 2026 8:36pm
· Source: financialmodelingprep.com